Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.69USD
−12.59 MUSD
About Genenta Science S.p.A.
Sector
CEO
Pierluigi Paracchi
Headquarters
Milan
Website
Employees (FY)
14
Founded
2014
FIGI
BBG013GNLJL6
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
